Therapeutic ranges in anticoagulant administration.
作者信息
Poller L
出版信息
Br Med J (Clin Res Ed). 1985 Jun 8;290(6483):1683-6. doi: 10.1136/bmj.290.6483.1683.
Abstract
摘要
相似文献
1
Therapeutic ranges in anticoagulant administration.抗凝治疗的治疗范围。
Br Med J (Clin Res Ed). 1985 Jun 8;290(6483):1683-6. doi: 10.1136/bmj.290.6483.1683.
2
Improved control of long-term anticoagulant therapy.长期抗凝治疗的控制得到改善。
Br Med J. 1968 May 11;2(5601):337-40. doi: 10.1136/bmj.2.5601.337.
3
Anticoagulant therapy: through a glass darkly.
Am Fam Physician. 1974 Feb;9(2):100-4.
4
"Therapeutic range" for oral anticoagulant therapy.口服抗凝治疗的“治疗范围”。
Chest. 1986 Feb;89(2 Suppl):11S-15S. doi: 10.1378/chest.89.2_supplement.11s.
5
The current status of therapy with anticoagulants.抗凝剂治疗的现状
Med Clin North Am. 1972 Jan;56(1):235-53. doi: 10.1016/s0025-7125(16)32438-5.
6
Management of venous thromboembolism.静脉血栓栓塞症的管理
Lancet. 1988 Feb 6;1(8580):275-7.
7
Anticoagulant therapy for venous thromboembolism.
Prog Hemost Thromb. 1989;9:1-27.
8
Empiric use of anticoagulant and fibrinolytic agents in surgical therapy.外科治疗中抗凝剂和纤溶药物的经验性应用。
Am Surg. 1974 Jan;40(1):15-21.
9
Anticoagulant therapy in right-sided thromboembolic disease.右侧血栓栓塞性疾病的抗凝治疗。
Chest. 1986 Jun;89(6):882-4. doi: 10.1378/chest.89.6.882.
10
Anticoagulant therapy for deep vein thrombosis: its proper application.深静脉血栓形成的抗凝治疗：其合理应用
Semin Vasc Surg. 1996 Mar;9(1):13-20.
引用本文的文献
1
Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.从皱瘤海鞘（脊索动物-被囊动物）体内分离并鉴定出一种具有低抗凝血酶活性的肝素。对静脉和动脉血栓形成模型有不同影响。
Thromb Res. 2007;121(2):213-23. doi: 10.1016/j.thromres.2007.03.025. Epub 2007 May 4.
2
The effects of lower intensity anticoagulation therapy on coagulation system in patients with mechanical prosthetic valves.
J Tongji Med Univ. 1999;19(1):56-8. doi: 10.1007/BF02895598.
3
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses.Bjork-Shiley机械心脏瓣膜与猪生物瓣膜的二十年比较。
Heart. 2003 Jul;89(7):715-21. doi: 10.1136/heart.89.7.715.
4
Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.普通诊所患者与医院抗凝门诊患者抗凝控制情况的比较。
Br J Gen Pract. 1993 Apr;43(369):152-4.
5
Control of oral anticoagulant treatment by chromogenic prothrombin assay.通过发色底物法凝血酶原测定控制口服抗凝治疗
J Clin Pathol. 1987 May;40(5):500-4. doi: 10.1136/jcp.40.5.500.
6
The Smith Kline & French lecture 1987. Clinical pharmacology and the art of bespoke prescribing.1987年史克必成讲座。临床药理学与定制处方的艺术。
Br J Clin Pharmacol. 1988 Oct;26(4):339-45. doi: 10.1111/j.1365-2125.1988.tb03390.x.
7
Warfarin and cataract extraction.华法林与白内障摘除术
Br J Ophthalmol. 1989 Sep;73(9):702-3. doi: 10.1136/bjo.73.9.702.
8
Control of warfarin therapy.华法林治疗的控制
Postgrad Med J. 1989 Sep;65(767):611-2. doi: 10.1136/pgmj.65.767.611.
9
Clinical problems in patients with prosthetic heart valves.人工心脏瓣膜患者的临床问题。
J R Coll Physicians Lond. 1990 Jul;24(3):167-72.
10
Safety of anticoagulation in the elderly: reasons for discontinuing therapy.老年人抗凝治疗的安全性：治疗中断的原因
Postgrad Med J. 1992 Oct;68(804):824-8. doi: 10.1136/pgmj.68.804.824.
本文引用的文献
1
PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY.预防性抗凝治疗的受伤患者的凝血酶原时间和血栓试验
Lancet. 1964 Jan 18;1(7325):124-9. doi: 10.1016/s0140-6736(64)92218-4.
2
Postcoital examination of semen.性交后精液检查。
Lancet. 1959 Nov 28;2(7109):974. doi: 10.1016/s0140-6736(59)91625-3.
3
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.抗凝药物治疗肺栓塞的对照试验。
Lancet. 1960 Jun 18;1(7138):1309-12. doi: 10.1016/s0140-6736(60)92299-6.
4
Dosage and control of oral anticoagulants: an international collaborative survey.
Br J Haematol. 1982 Jul;51(3):479-85. doi: 10.1111/j.1365-2141.1982.tb02805.x.
5
Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.皮下注射调整剂量肝素与华法林钠在静脉血栓形成长期治疗中的比较
N Engl J Med. 1982 Jan 28;306(4):189-94. doi: 10.1056/NEJM198201283060401.
6
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.不同强度的口服抗凝治疗在近端静脉血栓形成治疗中的应用
N Engl J Med. 1982 Dec 30;307(27):1676-81. doi: 10.1056/NEJM198212303072704.
7
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.组织型纤溶酶原激活剂用于进展性心肌梗死患者的冠状动脉溶栓治疗。
N Engl J Med. 1984 Mar 8;310(10):609-13. doi: 10.1056/NEJM198403083101001.
8
Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction.西华盛顿州急性心肌梗死冠状动脉内链激酶随机试验。
N Engl J Med. 1983 Dec 15;309(24):1477-82. doi: 10.1056/NEJM198312153092402.
9
Progress in laboratory control of oral anticoagulants.口服抗凝剂实验室控制的进展。
Lancet. 1982 Aug 7;2(8293):318-20. doi: 10.1016/s0140-6736(82)90283-5.
10
Anticoagulants in coronary heart disease--retrospect and prospect.冠心病中的抗凝剂——回顾与展望
Lancet. 1981 Jan 31;1(8214):257-62. doi: 10.1016/s0140-6736(81)92095-x.
Zotero 插件